The lung is an exquisitely radiosensitive organ that can be damaged by external beam radiation therapy. The degree of pulmonary injury is determined by the volume of lung irradiated, the dose and rate of exposure, and potentiating factors
Pembrolizumab is a programmed death receptor-1 (PD 1)-blocking antibody. Pembrolizumab is a humanized monoclonal IgG4 kappa antibody with an approximate molecular weight of 149 kDa.
Docetaxel is an antineoplastic agent belonging to the taxoid family indicated for breast cancer, Non-small Cell Lung Cancer (NSCLC), Castration-Resistant Prostate Cancer (CRPC), Gastric Adenocarcinoma and Squamous Cell Carcinoma
